Aker Biomarine AS (AKBM) — Cash Flow-to-Debt Ratio
Aker Biomarine AS (AKBM) has a Cash Flow-to-Debt Ratio of -0.03x as of June 2025, meaning its operating cash flow of Nkr-6.90 Million could theoretically repay 0% of its total liabilities (Nkr237.50 Million) in one year. See Aker Biomarine AS (AKBM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aker Biomarine AS Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Aker Biomarine AS across 9 annual periods. Also explore Aker Biomarine AS (AKBM) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Aker Biomarine AS (2016–2024)
Year-by-year debt coverage analysis for Aker Biomarine AS. For market capitalisation and broader financial context, see market value of Aker Biomarine AS.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | Nkr12.20 Million | Nkr213.50 Million | ▼ -44.5% |
| 2023 | 0.10x | Nkr47.40 Million | Nkr460.60 Million | ▲ +203.8% |
| 2022 | 0.03x | Nkr15.10 Million | Nkr445.80 Million | ▲ +1698.7% |
| 2021 | 0.00x | Nkr729.00K | Nkr387.12 Million | ▲ +101.2% |
| 2020 | -0.16x | Nkr-51.04 Million | Nkr327.26 Million | ▼ -781.4% |
| 2019 | 0.02x | Nkr12.31 Million | Nkr537.68 Million | ▼ -27.1% |
| 2018 | 0.03x | Nkr7.89 Million | Nkr251.43 Million | ▲ +8.9% |
| 2017 | 0.03x | Nkr9.17 Million | Nkr318.12 Million | ▼ -71.6% |
| 2016 | 0.10x | Nkr20.88 Million | Nkr205.32 Million | — |